Display options
Cite
Setny M, Jankowski P, Kamiński K, et al. Secondary prevention of coronary heart disease in Poland: does gender matter? Results from POLASPIRE survey. Pol Arch Intern Med. 2021;doi: 10.20452/pamw.16179.
Setny, M., Jankowski, P., Kamiński, K., Gąsior, Z., Haberka, M., Czarnecka, D., Pająk, A., Kozieł, P., Szóstak-Janiak, K., Sawicka, E., Stachurska, Z., & Kosior, D. A. (2021). Secondary prevention of coronary heart disease in Poland: does gender matter? Results from POLASPIRE survey. Polish archives of internal medicine, . https://doi.org/10.20452/pamw.16179
Setny, Małgorzata, et al. "Secondary prevention of coronary heart disease in Poland: does gender matter? Results from POLASPIRE survey." Polish archives of internal medicine vol. (2021). doi: https://doi.org/10.20452/pamw.16179
Setny M, Jankowski P, Kamiński K, Gąsior Z, Haberka M, Czarnecka D, Pająk A, Kozieł P, Szóstak-Janiak K, Sawicka E, Stachurska Z, Kosior DA. Secondary prevention of coronary heart disease in Poland: does gender matter? Results from POLASPIRE survey. Pol Arch Intern Med. 2021 Dec 22; doi: 10.20452/pamw.16179. Epub 2021 Dec 22. PMID: 34935325.
Copy Download .nbib Format: NLM
Share it on

Pol Arch Intern Med. 2021 Dec 22; doi: 10.20452/pamw.16179. Epub 2021 Dec 22.

Secondary prevention of coronary heart disease in Poland: does gender matter? Results from POLASPIRE survey.

Polish archives of internal medicine

Małgorzata Setny, Piotr Jankowski, Karol Kamiński, Zbigniew Gąsior, Maciej Haberka, Danuta Czarnecka, Andrzej Pająk, Paweł Kozieł, Karolina Szóstak-Janiak, Emilia Sawicka, Zofia Stachurska, Dariusz A Kosior

PMID: 34935325 DOI: 10.20452/pamw.16179

Abstract

INTRODUCTION: The adherence to health-promoting behaviors intended to mitigate modifiable risk factors plays an important role in the secondary CV prevention.

OBJECTIVES: To evaluate gender differences in the prevalence and control of risk factors in patients with coronary heart disease (CHD).

PATIENTS AND METHODS: The study included 1236 patients with acute coronary syndrome or coronary revascularization within the last 6-24 months. Definitions of risk factors and treatment goals are based on the 2016 ESC guidelines on cardiovascular prevention.

RESULTS: The prevalence of modifiable risk factors in both sexes was high and their control inadequate. Women were older (P <0.001) and had higher accumulation of multiple CV risk factors than men (P = 0.036). They had more frequently central obesity (P <0.001) and reduced GFR values (P <0.001). Women more often experienced anxiety (P <0.001), reported lower levels of education (P <0.001) and lower income (P = 0.001), and in the youngest age group were more likely to be exposed to the secondhand smoking (P = 0.01). A large fraction of study patients, men and women alike, did not meet the recommended therapeutic goals. For both sexes, participation in cardiac rehabilitation programs was associated with more frequent attainment of the recommended level of physical activity (P = 0.046) and smoking cessation (P = 0.010).

CONCLUSIONS: The prevalence of CV risk factors in CHD patients is high, especially in women. Therapeutic goals are met infrequently in both genders. This situation calls for widening the access to educational programs and higher attention to their proper implementation.

Publication Types